RNA SG&A Expenses

Atrium Therapeutics Inc · SG&A Expenses

RNA logo

RNA SG&A Expenses

Latest reported$60.44M
RNA SG&A Expenses ($41.68M → $60.44M)
High-resolution chart · PNG

RNA sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
41,676,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.